IIA
DGX icon

ICW Investment Advisors’s Quest Diagnostics DGX Stock Holding History

ICW Investment Advisors’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.51M Sell
11,828
-12
-0.1% -$2.35K 0.88% 42
2026
Q1 		$2.32M Buy
11,840
+258
+2% +$50.1K 0.84% 44
2025
Q4 		$2.01M Buy
11,582
+132
+1% +$24K 0.73% 48
2025
Q3 		$2.18M Buy
11,450
+369
+3% +$65.5K 0.79% 45
2025
Q2 		$1.99M Sell
11,081
-24
-0.2% -$4.17K 0.79% 46
2025
Q1 		$1.88M Buy
11,105
+43
+0.4% +$7.06K 0.77% 49
2024
Q4 		$1.67M Sell
11,062
-170
-2% -$26.4K 0.7% 56
2024
Q3 		$1.74M Sell
11,232
-68
-0.6% -$10.2K 0.73% 57
2024
Q2 		$1.55M Sell
11,300
-267
-2% -$36.6K 0.7% 57
2024
Q1 		$1.54M Buy
11,567
+314
+3% +$40.7K 0.68% 61
2023
Q4 		$1.55M Buy
11,253
+148
+1% +$19.5K 0.76% 54
2023
Q3 		$1.35M Buy
11,105
+237
+2% +$31.6K 0.73% 56
2023
Q2 		$1.53M Buy
10,868
+302
+3% +$41.6K 0.82% 52
2023
Q1 		$1.49M Buy
10,566
+305
+3% +$43.6K 0.85% 50
2022
Q4 		$1.61M Sell
10,261
-31
-0.3% -$4.46K 0.96% 44
2022
Q3 		$1.26M Buy
10,292
+85
+0.8% +$11.2K 0.85% 52
2022
Q2 		$1.36M Buy
10,207
+45
+0.4% +$6.13K 0.86% 52
2022
Q1 		$1.39M Buy
10,162
+111
+1% +$15.5K 0.8% 53
2021
Q4 		$1.74M Buy
10,051
+318
+3% +$48.4K 0.97% 42
2021
Q3 		$1.41M Buy
9,733
+91
+0.9% +$13.3K 0.91% 50
2021
Q2 		$1.27M Buy
9,642
+147
+2% +$19.2K 0.83% 55
2021
Q1 		$1.22M Buy
9,495
+134
+1% +$16.5K 0.84% 53
2020
Q4 		$1.11M Sell
9,361
-262
-3% -$31.9K 0.79% 55
2020
Q3 		$1.1M Buy
9,623
+140
+1% +$16.5K 0.83% 55
2020
Q2 		$1.08M Buy
9,483
+237
+3% +$25.1K 0.88% 51
2020
Q1 		$742K Buy
9,246
+500
+6% +$51.8K 0.7% 62
2019
Q4 		$934K Buy
+8,746
New +$912K 0.76% 61

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

ICW Investment Advisors's DGX Position: Q2 2026 in Review

ICW Investment Advisors reduced its Quest Diagnostics (DGX) stake by 0.1% in Q2 2026, selling an estimated $2.35K and leaving 11,828 shares worth $2.51M. The position accounts for 0.88% of the portfolio, ranked #42.

ICW Investment Advisors first reported a position in DGX in Q4 2019 and has held it in 27 quarters since. 1,111 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • ICW Investment Advisors held 11,828 shares of Quest Diagnostics worth $2.51M as of Q2 2026.
  • ICW Investment Advisors sold 12 Quest Diagnostics shares in Q2 2026, an estimated $2.35K.
  • Quest Diagnostics made up 0.88% of ICW Investment Advisors's portfolio in Q2 2026, its #42 holding.
  • ICW Investment Advisors first reported a position in Quest Diagnostics in Q4 2019 and has held it in 27 quarters since.
  • 1,111 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on ICW Investment Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.